UBS Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $22.2M | Sell |
|
|||||
|
2021
Q2 | $49.9M | Sell |
|
|||||
|
2021
Q1 | $35.3M | Sell |
|
|||||
|
2020
Q4 | $48.5M | Buy |
|
|||||
|
2020
Q3 | $19.6M | Sell |
|
|||||
|
2020
Q2 | $34.3M | Sell |
|
|||||
|
2020
Q1 | $39.6M | Sell |
|
|||||
|
2019
Q4 | $48.3M | Sell |
|
|||||
|
2019
Q3 | $35M | Sell |
|
|||||
|
2019
Q2 | $38.9M | Buy |
|
|||||
|
2019
Q1 | $35.4M | Buy |
|
|||||
|
2018
Q4 | $7.91M | Buy |
|
|||||
|
2018
Q3 | $7.71M | Sell |
|
|||||
|
2018
Q2 | $7.44M | Buy |
|
|||||
|
2018
Q1 | $5.75M | Sell |
|
|||||
|
2017
Q4 | $5.53M | Sell |
|
|||||
|
2017
Q3 | $3.54M | Buy |
|
|||||
|
2017
Q2 | $900K | Sell |
|
|||||
|
2017
Q1 | $968K | Buy |
|
|||||
|
2016
Q4 | $815K | Buy |
|
|||||
|
2016
Q3 | $1.56M | Buy |
|
|||||
|
2016
Q2 | $19K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $3K | Sell |
|
|||||
|
2015
Q3 | $11K | Buy |
|
|||||
|
2015
Q2 | $14K | Sell |
|
|||||
|
2015
Q1 | $65K | Buy |
|